UK markets closed

Ovid Therapeutics Inc. (OVID)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.0600-0.0100 (-0.33%)
At close: 04:00PM EDT
3.1500 +0.09 (+2.94%)
After hours: 07:26PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-68,664
-52,339
-54,169
122,835
-81,036
Depreciation & amortisation
998.606
1,597
1,382
237.079
306.848
Stock-based compensation
6,142
7,285
6,557
5,054
7,525
Change in working capital
-2,836
2,386
-8,231
-16,814
21,819
Accounts payable
-2,108
1,750
-5,174
1,702
2,334
Other working capital
-59,568
-45,918
-56,646
118,422
-51,975
Other non-cash items
-2,706
-2,706
-1,220
7,300
-199.408
Net cash provided by operating activities
-58,050
-45,781
-55,227
118,612
-51,584
Cash flows from investing activities
Investments in property, plant and equipment
-1,518
-137.455
-1,419
-189.408
-390.68
Acquisitions, net
-2,500
-10,000
-2,500
-1,632
0
Purchases of investments
-108,858
-112,443
-172,964
0
-9,961
Sales/maturities of investments
30,000
120,000
90,000
0
45,000
Other investing activities
-
-
-1,000
-
-
Net cash used for investing activities
-83,876
-2,581
-87,883
-1,821
34,648
Cash flows from financing activities
Common stock issued
-
-
-
0
46,731
Other financing activities
30,000
30,000
-
-21.314
-163.25
Net cash used provided by (used for) financing activities
333.437
30,535
180.658
904.082
47,072
Net change in cash
-141,592
-17,826
-142,930
117,694
30,137
Cash at beginning of period
201,780
46,799
189,728
72,034
41,897
Cash at end of period
60,187
28,972
46,799
189,728
72,034
Free cash flow
Operating cash flow
-58,050
-45,781
-55,227
118,612
-51,584
Capital expenditure
-1,518
-137.455
-1,419
-189.408
-390.68
Free cash flow
-59,568
-45,918
-56,646
118,422
-51,975